A morphometric study of the spatial patterns of TDP-43 immunoreactive neuronal inclusions in frontotemporal lobar degeneration (FTLD) with progranulin (GRN) mutation

Histology and Histopathology

Volumn 26, Issue 2, 2011, Pages 185-190

  Armstrong, Richard A ^a   Cairns, Nigel J ^b  

^a ASTON UNIVERSITY   (United Kingdom)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Frontotemporal lobar degeneration with TDP 43 proteinopathy (FTLD TDP); Progranulin (GRN) mutation; Spatial topography; TAR DNA binding protein (TDP 43)

Indexed keywords

DNA BINDING PROTEIN; GRN PROTEIN, HUMAN; PROTEIN PRECURSOR; PROTEIN TDP-43; SIGNAL PEPTIDE; TAR DNA BINDING PROTEIN;

AGED; ARTICLE; BRAIN; CELL INCLUSION; CELL NUCLEUS INCLUSION BODY; FEMALE; FRONTOTEMPORAL DEMENTIA; GENETICS; HUMAN; MALE; METABOLISM; MIDDLE AGED; MUTATION; NERVE CELL; NEUROFIBRILLARY TANGLE; ORGAN SIZE; PATHOLOGY; TDP 43 PROTEINOPATHY;

AGED; AGED, 80 AND OVER; BRAIN; DNA-BINDING PROTEINS; FEMALE; FRONTOTEMPORAL LOBAR DEGENERATION; HUMANS; INCLUSION BODIES; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTRANUCLEAR INCLUSION BODIES; MALE; MIDDLE AGED; MUTATION; NEUROFIBRILLARY TANGLES; NEURONS; ORGAN SIZE; PROTEIN PRECURSORS; TDP-43 PROTEINOPATHIES;

EID: 78651268247     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Armstrong R. A. (1993a). The usefulness of spatial pattern analysis in understanding the pathogenesis of neurodegenerative disorders, with particular reference to plaque formation in Alzheimer's disease. Neurodegeneration 2, 73-80.
2. Armstrong R. A. (1993b). Is the clustering of neurofibrillary tangles in Alzheimer's patients related to the cells of origin of specific corticocortical projections? Neurosci. Lett. 160, 57-60.
3. Armstrong R. A. (1997). Analysis of spatial patterns in histological sections of brain tissue. J. Neurosc. Meth. 73, 141-147.
4. Armstrong R. A. (2003). Measuring the degree of spatial correlation between histological features in thin sections of brain tissue. Neuropathology 23, 245-253.
5. Armstrong R. A. (2006). Methods of studying the planar distribution of objects in histological sections of brain tissue. J. Micros. (Oxf.) 221, 153-158.
6. Armstrong R. A. and Cairns N. J. (2006). Topography of α-internexinpositive neuronal aggregates in 10 patients with neuronal intermediate filament inclusion disease. Eur. J. Neurol. 13, 528-532.
7. Armstrong R. A., Cairns N. J. and Lantos P. L. (1997). Dementia with Lewy bodies: Clustering of Lewy bodies in human patients. Neurosci. Lett. 224, 41-44.
8. Armstrong R. A., Cairns N. J. and Lantos P. L. (1998). Clustering of Pick bodies in Pick's disease. Neurosci. Lett. 242, 81-84.
9. Armstrong R. A., Cairns N. J. and Lantos P. L. (1999). Clustering of cerebral cortical lesions in patients with corticobasal degeneration. Neurosci. Lett. 268, 5-8.
10. Armstrong R. A., Cairns N. J. and Lantos P. L. (2001). What does the study of spatial patterns tell us about the pathogenesis of neurodegenerative disorders? Neuropathology 21, 1-12.
11. Armstrong R. A., Lantos P. L. and Cairns N. J. (2004). Spatial patterns of α-synuclein positive glial cytoplasmic inclusions in multiple system atrophy. Move. Disord. 19, 109-112.
12. Armstrong R. A., Lantos P. L. and Cairns N. J. (2008). What determines the molecular composition of abnormal protein aggregates in neurodegenerative disease? Neuropathology 28, 351-365.
13. Armstrong R. A., Ellis W., Hamilton R. L., Mackenzie I. R. A., Hedreen J., Gearing M., Montine T., Vonsattel J.-P., Head E., Lieberman A. P. and Cairns N. J. (2010). Neuropathological heterogeneity in frontotemporal lobar degeneration with TDP-43 proteinopathy: a quantitative study of 94 cases using principal components analysis. J. Neural Transm. 117, 227-239.
14. Baker M., Mackenzie I. R., Pickering-Brown S. M., Gass J., Rademakers R., Lindholm C., Snowden J., Adamson J., Sadovnick A. D., Rollinson S., Cannon A., Dwosh E., Neary D., Melquist S., Richardson A., Dickson D., Berger Z., Eriksen J., Robinson T., Zehr C., Dickey C. A., Crook R., McGowan E., Mann D., Boeve B., Feldman H. and Hutton M. (2006). Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature 442, 916-919. (Pubitemid 44285946)
15. Beck J., Rohrer J. D., Campbell T., Isaacs A., Morrison K. E., Goodall E. F., Warrington E. K., Stevens J., Revesz T., Hoton J., Al-Sarraj S., King A., Scabill R., Warren J. D., Rossor M. N., Collinge J. and Mead S. (2008). A distinct clinical, neuropsychological and radiological phenotype is associated with progranulin gene mutation in a large UK series. Brain 131, 706-720.
16. Behrens M. I., Mukherjee O., Tu P. H., Liscic R. M., Grinberg L. T., Carter D., Paulsmeyer K., Taylor-Reinwald L., Gitcho M., Norton J. B., Chakraverty S., Goate A. M., Morris J. C. and Cairns N. J. (2007). Neuropathologic heterogeneity in HDDD1: a familial frontotemporal lobar degeneration with ubiquitin-positive inclusions and progranulin mutation. Alz. Dis. Assoc. Disord. 21, 1-7.
17. Bigio E. H., Lipton A. M., White C. L., Dickson D. W. and Hirano A. (2003). Frontotemporal dementia and motor neurone degeneration with neurofilament inclusion bodies: additional evidence for overlap between FTD and ALS. Neuropathol. App. Neurobiol. 29, 239-253.
18. Braak H., Braak E. and Bohl J. (1993). Staging of Alzheimer-related cortical destruction. Eur. Neurol. 33, 403-408.
19. Cairns N. J. and Ghoshal N. (2010). FUS A new actor on the frontotemporal lobar degeneration stage. Neurology 74, 354-356.
20. Cairns N. J., Perry R. H., Jaros E., Burn D., McKeith I. G., Lowe J. S., Holton J., Rossor M. N., Skullerud K., Duyckaerts C., Cruz-Sanchez F. F. and Lantos PL. (2003). Patients with a novel neurofilamentopathy: dementia with neurofilament inclusions. Neurosci. Lett. 341, 177-180.
21. Cairns N. J., Zhukareva V., Uryu K., Zhang B., Bigio E., Mackenzie I. R. A., Gearing M., Duyckaerts C., Yokoo H., Nakazato Y., Jaros E., Perry R. H., Lee V. M. Y. and Trojanowski J. Q. (2004). Alphainternexin is present in the pathological inclusions of neuronal intermediate filament inclusion disease. Am. J. Pathol. 164, 2153-2161.
22. Cairns N. J., Neumann M., Bigio E. H., Holm I. E., Troost D., Hatanpaa K. J., Foong C., White C. L. III., Schneider J. A., Kretzschmar H. A., Carter D., Taylor-Reinwald L., Paulsmeyer K., Strider J., Gitcho M., Goate A. M., Morris J. C., Mishra M., Kwong L. K., Steiber A., Xu Y., Forman M. S., Trojanowski J. Q., Lee V. M. Y. and Mackenzie I. R. A. (2007a). TDP-43 familial and sporadic frontotemporal lobar degeneration with ubiquitin inclusions. Am. J. Pathol. 171, 227-240.
23. Cairns N. J., Bigio E. H., Mackenzie I. R. A., Neumann M., Lee V. M. Y., Hatanpaa K., White C. L., Schneider J. A., Grinberg L. T., Halliday G., Duyckaerts C., Lowe J., Holm I., Tolnay M., Okamoto K., Yokoo H., Murayama S., Woulfe J., Munoz D. G., Dickson D. W., Ince P. G., Trojanowski J. Q. and Mann D. M. A. (2007b). Neuropathologic diagnostic and nosological criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration. Acta Neuropathol. 114, 5-22.
24. Cruts M., Gijselink I., van der Z. J., Engelborgs S., Wils H., Pirici D., Radamakers R., Vandenberghe R., Dermaut B., Martin J. J., van Duijn C., Peeters K., Sciot R., Santens P., De Pooter T., Mattheijssens M., van den B. M., Cuijt I., Vennekens K., De Deyn P. P., Kumar-Singh S. and Van Broeckhoven C. (2006). Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21. Nature 442, 920-924.
25. Davidson Y., Kelley T., Mackenzie I. R. A., Pickering Brown S., Du Plessis D., Neary D., Snowden J. S. and Mann D. M. A. (2007). Ubiquinated pathological lesions in frontotemporal lobar degeneration contain TAR DNA-binding protein, TDP-43. Acta Neuropathol. 113, 521-533.
26. De Lacoste M. and White C. L. III. (1993). The role of cortical connectivity in Alzheimer's disease pathogenesis: a review and model system. Neurobiol. Aging 14, 1-16.
27. Delatour B., Blanchard V., Pradier L. and Duyckaerts C. (2004). Alzheimer pathology disorganizes cortico-cortical circuitry: direct evidence from a transgenic animal model. Neurobiol. Dis. 16, 41-47.
28. Forman M. S., Mackenzie I. R., Cairns N. J., Swanson E., Boyer P. J., Drachman D. A., Jhaveri B. S., Karlawish J. H., Pestrvik A., Smith T. N., Tu P. H., Watts G. D. J., Markesbery W. R., Smith C. D. and Kimonis V. E. (2006). Novel ubiquitin neuropathology in frontotemporal dementia with valosin-containing protein gene mutations. J. Neuropathol. Exp. Neurol. 65, 571-581.
29. Goedert M., Spillantini M. G., Serpell L. C., Berriman J., Smith M. J., Jakes R., and Crowther R. A. (2001). From genetics to pathology: tau and alpha-synuclein assemblies in neurodegenerative diseases. Phil. Trans. Roy. Soc. Lond. B. Biol. Sci. 356, 213-227.
30. Hiorns R. W., Neal J. W., Pearson R. C. A. and Powell T. P. S. (1991). Clustering of ipsilateral cortico-cortical projection neurons to area 7 in the rhesus monkey. Proc. Roy. Soc. Lond. 246, 1-9.
31. Josephs K. A., Holton J. L., Rossor M. N., Braendgaard H., Ozawa T., Fox N. C., Petersen R. C., Pearl G. S., Ganguly M., Rosa. P., Laursen H., Parisi J. E., Waldemar G., Quinn N. P., Dickson D. W. and Revesz T. (2003). Neurofilament inclusion body disease: a new proteinopathy? Brain 126, 2291-2303.
32. Josephs K. A., Knopman D. S., Whitwell J. L., Boeve B. F., Parisi J. E., Petersen R. C. and Dickson D. W. (2005). Survival in the two variants of tau negative FTLD: FTLD-U versus FTLD-MND. Neurology 65, 645-647.
33. Kersaitis C., Holliday G. M., Xuereb J. H., Pamphlett R., Bak T. H., Hodges J. R. and Kril J. J. (2006). Ubiquitin-positive inclusions and progression of pathology in FTD and MND identifies a group with mainly early pathology. Neuropathol. Appl. Neurobiol. 32, 83-91.
34. Kovari E., Gold G., Giannakopoulos P. and Bouras C. (2004). Cortical ubiquitin positive inclusions in frontotemporal dementia without motor neuron disease: a quantitative immunocytochemical study. Acta Neuropathol. 108, 207-212.
35. Mackenzie I. R. A., Baker M., Pickering-Brown S., Hsinng G. Y. R., Lindholm C., Dwosh E., Cannon A., Rademakers R., Hutton M. and Feldman H. H. (2006). The neuropathology of frontotemporal lobar degeneration caused by mutations in the progranulin gene. Brain 129, 3081-3090.
36. Mukherjee O., Pastor P., Cairns N. J., Chakraaverty S., Kauwe J. S. K., Shears S., Behrens M. I., Budde J., Hinrichs A. L., Norton J., Levitch D., Taylor-Reinwald L., Gitcho M., Tu P. H., Grinberg L. T., Liscic R. M., Armendariz J., Morris J. C. and Goate A. M. (2006). HDDD2 is a familial frontotemporal lobar degeneration with ubiquitin-positive tau-negative inclusions caused by a missense mutation in the signal peptide of progranulin. Ann. Neurol. 60, 314-322.
37. Neumann M., Igaz L. M., Kwong L. K., Nakashima-Yasuda H., Kolb S. J., Dreyfuss G., Kretzschmar H. A., Trojanowski J. Q. and Lee V. M. Y. (2007). Absence of heterogeneous nuclear riboproteins and survival neuron protein (TDP-43) positive inclusions in frontotemporal lobar degeneration. Acta Neuropathol. 113, 543-548.
38. Pirici D., Vandenberghe R., Rademakers R., Dermant B., Cruts M., Vennekens K., Cuijt I., Lubke U., Centerick C., Martin J. J., Van Broeckhoven C. and Kumar-Singh S. (2006). Characterization of ubiquinated intraneuronal inclusions in a novel Belgian frontotemporal lobar degeneration family. J. Neuropathol. Exp. Neurol. 65, 289-301.
39. Rademakers R. and Hutton M. (2007). The genetics of frontotemporal lobar degeneration. Curr. Neurol. Neurosci. Rep. 7, 434-442.
40. Rollinson S., Rizzu P., Sikkink S., Baker M., Halliwell N., Snowden J., Traynor B. J., Ruano D., Cairns N., Rohrer J. D., Mead S., Collinge J., Rossor M., Akay E., Gueireiro R., Rademakers R., Morrison K. E., Pastor P., Alonso E., Martinez-Lage P., Graff-Radford N., Neary D., Henlink P., Mann D. M. A., Van Swieten J. and Pickering-Brown S. M. (2009). Ubiquitin associated protein 1 is a risk factor for frontotemporal lobar degeneration. Neurobiol. Aging 30, 656-665.
41. Snowden J., Neary D. and Mann D. (2007). Frontotemporal lobar degeneration: clinical and pathological relationships. Acta Neuropathol. 114, 31-38.
42. Tolnay M. and Probst A. (2002). Frontotemporal lobar degeneration-tau as a pied piper? Neurogenetics 4, 63-75.
43. Woulfe J., Kertesz A. and Munoz D. G. (2001). Frontotemporal dementia with ubiquinated cytoplasmic and intranuclear inclusions. Acta Neuropathol. 102, 94-102.
44. Yaguchi M., Fujita Y., Amari M., Takatama M., Al-Sarraj S., Leigh P. N. and Okamoto K. (2004). Morphological differences of intraneural ubiquitin positive inclusions in the dentate gyrus and parahippocampal gyrus of motor neuron disease with dementia. Neuropathology 24, 296-301.